Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test

Qi Huang,Zheng Liu,Yipei Yu,Zhiwei Rong,Peiyu Wang,Shaodong Wang,Hao Wu,Xiang Yan,William C. Cho,Teng Mu,Jilun Li,Jia Zhao,Mantang Qiu,Yan Hou,Xiangnan Li
DOI: https://doi.org/10.1038/s41416-023-02547-w
IF: 9.075
2024-01-05
British Journal of Cancer
Abstract:Neoadjuvant chemo-immunotherapy combination has shown remarkable advances in the management of esophageal squamous cell carcinoma (ESCC). However, the identification of a reliable biomarker for predicting the response to this chemo-immunotherapy regimen remains elusive. While computed tomography (CT) is widely utilized for response evaluation, its inherent limitations in terms of accuracy are well recognized. Therefore, in this study, we present a novel technique to predict the response of ESCC patients before receiving chemo-immunotherapy by testing volatile organic compounds (VOCs) in exhaled breath.
oncology
What problem does this paper attempt to address?